Neuren Pharmaceuticals (NEU) News Today → ‘America’s Top Trader’ Who Predicted the Biggest Financial Events of The Last 30 Years, Issues New Warning… (From InvestorPlace) (Ad) Free NEU Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 29 at 7:54 PM | msn.comThese ASX shares could rise 25% to 35%May 29 at 9:53 AM | fool.com.auWhy Cettire, Neuren, Peter Warren, and Qantas shares are falling todayMay 28, 2024 | afr.comASX climbs; Cettire, Lendlease shares jumpMay 28, 2024 | msn.comASX200 rises in strong rebound on May 27 trading dayMay 28, 2024 | msn.comAs it happened: ASX up 0.8pc with solid gains across the board to finish just shy of a record closeMay 28, 2024 | finance.yahoo.comNeuren Pharmaceuticals’ NNZ-2591 shows promise in trial for Pitt Hopkins syndromeMay 27, 2024 | fool.com.auThis ASX 200 stock can rocket to a record high: BrokerMay 27, 2024 | markets.businessinsider.comNeuren's NNZ-259 Phase 2 Trial Demonstrates Significant Improvements In Pitt Hopkins SyndromeMay 23, 2024 | msn.comASX 200 healthcare stock up 40% in 6 months halted ahead of major trial resultsMay 9, 2024 | msn.comWhy this high-flying ASX 200 healthcare stock just crashed 11%April 3, 2024 | msn.comASX loses 1.3% on back of Wall Street decline, gold price hits new high and the world's richest people are getting richer — as it happenedApril 1, 2024 | finance.yahoo.comHere's Why Neuren Pharmaceuticals (ASX:NEU) Has Caught The Eye Of InvestorsMarch 26, 2024 | uk.finance.yahoo.com20 Biggest Health Care Companies in Australia, 2024March 18, 2024 | fool.com.auThe best ASX shares to invest $500 in right nowMarch 11, 2024 | fool.com.au$10k of savings? I'd buy these ASX 200 shares to grow my moneyMarch 3, 2024 | finance.yahoo.comNeuren Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their ModelsFebruary 29, 2024 | fool.com.auWhat's with the Neuren Pharmaceuticals share price today?February 28, 2024 | msn.comInflation remains at two-year low, Optus sacks extra 200 staff, Sony terminates 8pc of workforce, ASX finishes flat — as it happenedFebruary 28, 2024 | fool.com.auWhy is this ASX 200 pharmaceuticals stock crashing 15% today?February 16, 2024 | msn.comNeuren (NEU) Shares Plunge as Short Seller Targets Partner AcadiaFebruary 15, 2024 | fool.com.auThis ASX 200 healthcare share is diving 13% as short sellers take aimJanuary 18, 2024 | forbes.comStock Market Outlook In 2024January 15, 2024 | markets.businessinsider.comJefferies Keeps Their Buy Rating on Clinuvel Pharmaceuticals Limited (CLVLF)January 12, 2024 | fool.com.au3 pharma shares outshining the ASX index todayJanuary 8, 2024 | fool.com.auThe Neuren Pharmaceuticals share price is up 100% in 3 months: Can it keep rising?January 6, 2024 | fool.com.auThe No. 1 ASX 200 shares of each market sector in 2023January 4, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Innovent Biologics (IVBXF), Telix Pharmaceuticals Ltd. (TLPPF)December 26, 2023 | finance.yahoo.comAn Intrinsic Calculation For Neuren Pharmaceuticals Limited (ASX:NEU) Suggests It's 44% UndervaluedDecember 22, 2023 | fool.com.auWhy Boss Energy, Lynas, Neuren, and Ora Banda shares are rising todayDecember 19, 2023 | au.investing.comNeuren Pharmaceuticals' shares surge on positive Phase 2 clinical trial resultsDecember 18, 2023 | fool.com.auGuess which ASX 200 stock was just upgraded and tipped to rise 20%+December 17, 2023 | fool.com.auWhy is this ASX 200 healthcare stock surging 32% on Monday?December 13, 2023 | finance.yahoo.comAustralia Shares Rise, Helped by Healthcare StocksDecember 10, 2023 | afr.comNew fund targets companies battered by market doubtsNovember 6, 2023 | morningstar.comNeuren Pharmaceuticals Ltd NEUNovember 3, 2023 | finance.yahoo.comAcadia (ACAD) Q3 Earnings and Sales Beat Estimates, Stock UpOctober 5, 2023 | fool.com.auBell Potter says these are the best ASX shares to buy in OctoberSeptember 26, 2023 | msn.comAcadia Pharmaceuticals: Difficult Market Masks ProgressSeptember 7, 2023 | markets.businessinsider.comWilsons downgrades Mayne Pharma Group (MAYNF) to a SellAugust 31, 2023 | markets.businessinsider.comBell Potter Keeps Their Buy Rating on Neuren Pharmaceuticals Limited (NURPF)August 30, 2023 | finance.yahoo.comIs Weakness In Neuren Pharmaceuticals Limited (ASX:NEU) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?August 22, 2023 | msn.comMove over Neuren – Bioshares reckons these ASX health stocks could pop with upcoming key catalystsAugust 3, 2023 | msn.comAcadia (ACAD) Q2 Earnings & Revenues Beat Estimates, '23 View UpAugust 2, 2023 | finance.yahoo.comAcadia Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operating OverviewJuly 19, 2023 | finance.yahoo.comAre Investors Undervaluing Neuren Pharmaceuticals Limited (ASX:NEU) By 23%?July 17, 2023 | 247wallst.comAcadia Pharmaceuticals Rights Deal and Bullish Outlook Sends Shares Surging 16%. Here's What to Expect.July 17, 2023 | finance.yahoo.comAcadia (ACAD) Soars 24.7%: Is Further Upside Left in the Stock?July 17, 2023 | msn.comAcadia Pharmaceuticals Rights Deal and Bullish Outlook Sends Shares Surging 16%. Here’s What To ExpectJuly 14, 2023 | msn.comWhy Are Acadia Pharmaceuticals Shares Trading Higher Today?July 14, 2023 | msn.comHere’s Why Acadia (NASDAQ:ACAD) Stock Shot Up 23% Yesterday Get Neuren Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NEU and its competitors with MarketBeat's FREE daily newsletter. Email Address The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made … Click here to see the presentation now. NEU Media Mentions By Week NEU Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEU News Sentiment▼0.570.80▲Average Medical News Sentiment NEU News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEU Articles This Week▼81▲NEU Articles Average Week Get Neuren Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NEU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Arno Therapeutics News Today Artelo Biosciences News Today Ascletis Pharma News Today Awakn Life Sciences News Today AXIM Biotechnologies News Today Baseline Productions News Today BerGenBio ASA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:NEU) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyMAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…AltimetryUnlock Explosive Gains with This Defense StockBehind the MarketsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin Pro Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuren Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
